Your browser doesn't support javascript.
loading
Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment.
Zecevic, Ksenija; Volcansek, Spela; Katsiki, Niki; Rizzo, Manfredi; Milardovic, Tanja Milicevic; Stoian, Anca Pantea; Banach, Maciej; Muzurovic, Emir.
Afiliação
  • Zecevic K; Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.
  • Volcansek S; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia; Medical Faculty Ljubljana, Ljubljana, Slovenia.
  • Katsiki N; Department of Nutritional Sciences and Dietetics, International Hellenic University, Thessaloniki, Greece; School of Medicine, European University Cyprus, Nicosia, Cyprus.
  • Rizzo M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
  • Milardovic TM; Internal Medicine Department, Endocrinology, Diabetology, and Metabolism Division, University Hospital of Split, Split, Croatia; University of Split School of Medicine, Split, Croatia.
  • Stoian AP; Diabetes, Nutrition and Metabolic diseases Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
  • Banach M; Department of Preventive Cardiology and Lipidology, Medical University of Lódz, Lodz, Poland; Department of Cardiology and Adult Congenital Heart Diseases, Polish Mother's Memorial Hospital Research Institute, Lódz, Poland; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of C
  • Muzurovic E; Faculty of Medicine, University of Montenegro, Podgorica, Montenegro; Department of Internal Medicine, Endocrinology Section, Clinical Center of Montenegro, Podgorica, Montenegro. Electronic address: dremir@t-com.me.
Prog Cardiovasc Dis ; 2024 Mar 19.
Article em En | MEDLINE | ID: mdl-38513726
ABSTRACT
Maturity-onset diabetes of the young (MODY) is a spectrum of clinically heterogenous forms of monogenic diabetes mellitus characterized by autosomal dominant inheritance, onset at a young age, and absence of pancreatic islets autoimmunity. This rare form of hyperglycemia, with clinical features overlapping with type 1 and type 2 diabetes mellitus, has 14 subtypes with differences in prevalence and complications occurrence which tailor therapeutic approach. MODY phenotypes differ based on the gene involved, gene penetrance and expressivity. While MODY 2 rarely leads to diabetic complications and is easily managed with lifestyle interventions alone, more severe subtypes, such as MODY 1, 3, and 6, require an individualized treatment approach to maintain a patient's quality of life and prevention of complications. This review summarizes current evidence on the presentation, diagnosis, and management of MODY, an example of a genetic cause of hyperglycemia that calls for a precision medicine approach.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Prog Cardiovasc Dis Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Prog Cardiovasc Dis Ano de publicação: 2024 Tipo de documento: Article